More about
Non-Dialysis Dependent Chronic Kidney Disease
News
May 20, 2024
2 min read
Save
Investigational drug that reduces hepcidin offers promise for treating anemia
LONG BEACH, Calif. — Researchers reported results from a phase 1b/2a placebo-controlled study of DISC-0974, an anti-hemojuvelin antibody to treat anemia in patients with chronic kidney disease.